Hemodynamics, diuretics, and nesiritide: A retrospective VMAC analysis

Clinical Cardiology

Volumn 32, Issue 9, 2009, Pages 530-536

  Young, James B ^a,c   Cheng, Mei ^b   Mills, Roger M ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b SCIOS INC   (United States)

^c CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUMETANIDE; CHLOROTHIAZIDE; CREATININE; DIURETIC AGENT; FUROSEMIDE; GLYCERYL TRINITRATE; HYDROCHLOROTHIAZIDE; METOLAZONE; NESIRITIDE; PLACEBO; TORASEMIDE;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FEMALE; HEART HEMODYNAMICS; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PATIENT CODING; PULMONARY ARTERY CATHETER; PULMONARY ARTERY OCCLUSION PRESSURE; RISK ASSESSMENT; SIDE EFFECT;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; CATHETERIZATION, SWAN-GANZ; CREATININE; DIURETICS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; HYPOTENSION; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NATRIURETIC PEPTIDE, BRAIN; PATIENT SELECTION; PROSPECTIVE STUDIES; PULMONARY WEDGE PRESSURE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME; UP-REGULATION; VASODILATOR AGENTS;

EID: 70249131799     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20620     Document Type: Article

References (25)

1. Butler J, Forman DE, Abraham WT, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J. 2004;147(2):331-338. (Pubitemid 38176835)
2. Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43(1):61-67. (Pubitemid 38045917)
3. Gottlieb SS, Abraham W, Butler J, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail. 2002;8(3):136-141. (Pubitemid 34857278)
4. Krumholz HM, Chen YT, Vaccarino V, et al. Correlates and impact on outcomes of worsening renal function in patients ≥65 years of age with heart failure. Am J Cardiol. 2000;85(9):1110-1113. (Pubitemid 30214258)
5. Smith GL, Vaccarino V, Kosiborod M, et al. Worsening renal function:what is a clinicallymeaningful change in creatinine during hospitalization with heart failure? J Card Fail. 2003;9(1):13-25. (Pubitemid 36356697)
6. Sackner-Bernstein JD, Skopicki HA, Aaronson KD Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005;111(12):1487-1491.
7. Abraham WT Serum creatinine elevations in patients receiving nesiritide are related to starting dose. Circulation. 2005;112(17 suppl II):589. Abstract 2789.
8. Publication Committee for the VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. 2002;287(12):1531-1540.
9. Cheng JW, Merl MY, Nguyen HM Effect of nesiritide on renal function: a retrospective review. Curr Med Res Opin. 2005;21(11):1857-1863.
10. Epstein BJ Elevations in serum creatinine concentration: concerning or reassuring? Pharmacotherapy. 2004;24(5):697-702.
11. Bakris GL, Weir MR Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med. 2000;160(5):685-693.
12. Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure: activation of the neurohumoral axis. Ann Intern Med. 1985;103(1):1-6.
13. Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with andwithout congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990;82(5):1724-1729. (Pubitemid 20367975)
14. McCurley JM, Hanlon SU, Wei SK, Wedam EF, Michalski M, Haigney MC Furosemide and the progression of left ventricular dysfunction in experimental heart failure. J Am Coll Cardiol. 2004;44(6):1301-1307. (Pubitemid 39208889)
15. Knight EL, Glynn RJ, McIntyre KM, Mogun H, Avorn J Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD). Am Heart J. 1999;138(5, pt 1):849-855. (Pubitemid 29523271)
16. Gottlieb SS, Brater DC, Thomas I, et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation. 2002;105(11):1348-1353. (Pubitemid 34260427)
17. Neuberg GW, Miller AB, O'Connor CM, et al. Diuretic resistance predictsmortality in patients with advanced heart failure. Am Heart J. 2002;144(1):31-38. (Pubitemid 34734752)
18. Domanski M, Norman J, Pitt B Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 2003;42(4):705-708. (Pubitemid 37000189)
19. Emerman CL, DeMarco T, Costanzo MR, Peacock WR Impact of intravenous diuretics on the outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry. J Card Fail. 2004;10(4 suppl 1):S116-S117. Abstract 368.
20. Eshaghian S, Horwich TB, Fonarow GC Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol. 2006;97(12):1759-1764. (Pubitemid 43817867)
21. Domanski M, Tian X, Haigney M, Pitt B Diuretic use, progressive heart failure, and death in patients in the DIG study. J Card Fail. 2006;12(5):327-332. (Pubitemid 43817590)
22. Hasselblad V, Gattis Stough W, Shah MR, et al. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail. 2007;9(10):1064-1069. (Pubitemid 47451811)
23. Ishii J, Nomura M, Nakamura Y, et al. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol. 2002;89(6):691-695. (Pubitemid 34230565)
24. Ahmed A, Aronow WS, Fleg JL Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function. Am Heart J. 2006;151(2):444-450. (Pubitemid 43144748)
25. Binanay C, Califf RM, Hasselblad V, et al. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness: the ESCAPE trial. JAMA. 2005;294(13):1625-1633.